Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
52
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety assessment of apatinib in patients with advanced gastric cancer: a meta-analysis

Jianxin Chen1 Department of Medical Oncology, Quzhou People’s Hospital, Quzhou, 324000, Zhejiang, People’s Republic of China
&
Junhui Wang2 Department of Radiation Oncology, Quzhou People’s Hospital, Quzhou, 324000, Zhejiang, People’s Republic of China, [email protected]Correspondence[email protected]
Pages 4149-4158 | Published online: 19 Jul 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chao Li, Rongfang Wu & Youzhong Xing. (2020) MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer. Cell Cycle 19:5, pages 601-609.
Read now

Articles from other publishers (2)

Xiaoying Li, Lin Li & Jiangying Wu. (2023) The members of the miR-148/152 family inhibit cancer stem cell-like properties in gastric cancer via negative regulation of ITGA5. Journal of Translational Medicine 21:1.
Crossref
Yajuan Lv, Yan Zhang, Jiandong Zhang, Ning Liang, Fengjun Liu & Ruixue Liu. (2019) Reversible posterior leukoencephalopathy syndrome following apatinib for gastric cancer in an adult. Medicine 98:46, pages e17787.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.